Project Grant R21AI187865
Award Date
7/18/25
Completion Date
6/30/27
Dollars Obligated
$433K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This federal Project Grant award of $643,718 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how interferon-regulatory factors (IRFs) and STAT transcription factors remodel the epigenome and chromosome organization of macrophages to reprogram their immune responses. The research aims to: 1) dissect the roles of innate immune IRFs in de novo enhancer formation, 2)...
This $606,609 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at the University of California, San Diego (UCSD) to develop T cell alloreactivity and organ transplant risk stratification models using high-resolution HLA and genomic data. The research aims to advance understanding of immune system responses and improve clinical outcomes for organ transplant recipients. The 5-year...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to evaluate the use of serum microRNA (miRNA) profiling to assist in the safe tapering of immunosuppression for liver transplant recipients. The $264,596 award will support a 3-phase study design to establish trial procedures, develop the protocol, and assess outcome measures. The research team, led by The...
This federal Project Grant award of $1,310,631.89, provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research), supports the development and optimization of antibody-targeted nanoparticle delivery systems to selectively target endothelial cells in human organ allografts. The goal is to prevent the expression of surface proteins that contribute to T cell-mediated rejection and improve long-term graft outcomes, thereby reducing the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $147,486.00 to the Icahn School of Medicine at Mount Sinai to conduct high-resolution immunological characterizations of a novel murine model of chronic hepacivirus infection. The goal is to study the evolution of immune dysfunction over the course of infection and better understand the molecular drivers of T cell exhaustion and viral...
This $814,790 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to uncover the immune mechanisms underlying hepatitis B virus (HBV) surface antigen clearance, which can lead to a clinical cure for chronic HBV infection. The principal investigators at the University of California, San Francisco (UCSF) will leverage mouse models and clinical samples from HBV patients to conduct a...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research at Georgetown University to establish cell type-specific biomarkers derived from cell-free methylated DNA (cfDNA) as novel viability parameters for assessing the quality and viability of donor livers during normothermic machine perfusion (NMP). The $429,000 grant, awarded from July 1, 2025 to June 30,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research grant program (CFDA 93.855) will support research to identify immune signatures that predict the risk of cytomegalovirus (CMV) disease in liver transplant recipients. The $832,910 award to the University of Washington will fund a 5-year study to characterize the humoral and cellular immune responses to CMV, including neutralizing antibodies and the...
This federal Project Grant award of $451,292.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to uncover neuronal mechanisms that orchestrate metabolic adaptations to bacterial infections, with a focus on delineating the role of the brain-liver axis in modulating metabolic responses. The research seeks to identify neurocircuits in the hypothalamus that monitor circulating lipoproteins and...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $599,541.00 to the University of Colorado-Denver to study the role of antigen-specific T cell responses in non-alcoholic steatohepatitis (NASH). The overarching goal is to define the timing of T cell clonal expansion, the antigens recognized by clonally expanded T cells, the antigen...